LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
+11.42%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.25B
AUM Growth
+$1.25B
(+6.1%)
Cap. Flow
+$6.76M
Cap. Flow
% of AUM
0.54%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
377
New
103
Increased
165
Reduced
63
Closed
19
Top Buys
| 1 |
InMode
INMD
|
$18.4M |
| 2 |
Merck
MRK
|
$18M |
| 3 |
KE Holdings
BEKE
|
$13.9M |
| 4 |
Huazhu Hotels Group
HTHT
|
$11.3M |
| 5 |
Insulet
PODD
|
$11.2M |
Top Sells
| 1 |
iShares Russell 1000 Value ETF
IWD
|
$38.6M |
| 2 |
iShares MSCI EAFE Value ETF
EFV
|
$33.9M |
| 3 |
iShares Russell 2000 Growth ETF
IWO
|
$33.7M |
| 4 |
AbbVie
ABBV
|
$18.6M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
$12.5M |
Sector Composition
| 1 | Healthcare | 45.52% |
| 2 | Financials | 14.68% |
| 3 | Consumer Discretionary | 13.33% |
| 4 | Technology | 10.6% |
| 5 | Industrials | 5.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Manulife Financial
MFC
$52.2B
| $29.1M | 2.33% | 1,204,270 +4,270 | +0.4% | +$103K |
|
2
Service Corp International
SCI
$11.1B
| $27.3M | 2.18% | 395,000 -5,000 | -1% | -$346K |
|
|
CIXX
3
DELISTED
CI Financial Corp.
CIXX
| $27M | 2.16% | 2,000,000 | – | – |
|
4
Thermo Fisher Scientific
TMO
$186B
| $26.2M | 2.1% | 47,639 +548 | +1% | +$302K |
|
5
IQVIA
IQV
$32.4B
| $25.2M | 2.02% | 123,018 +8,018 | +7% | +$1.64M |
|
6
Ameriprise Financial
AMP
$48.5B
| $25.1M | 2.01% | 80,702 -4,298 | -5% | -$1.34M |
|
7
DexCom
DXCM
$29.5B
| $24.3M | 1.94% | 214,791 -35,057 | -14% | -$3.97M |
|
8
Brunswick
BC
$4.15B
| $21.6M | 1.73% | 300,000 | – | – |
|
9
Charles Schwab
SCHW
$174B
| $21.5M | 1.72% | 258,765 +4,744 | +2% | +$395K |
|
10
BioMarin Pharmaceuticals
BMRN
$11.2B
| $21.3M | 1.71% | 206,213 -16,725 | -8% | -$1.73M |
|
|
11
Merck
MRK
$210B
| $20.2M | 1.61% | 181,952 +162,607 | +841% | +$18M |
|
12
Incyte
INCY
$16.5B
| $19.9M | 1.59% | 247,184 -18,889 | -7% | -$1.52M |
|
13
Pfizer
PFE
$141B
| $19.8M | 1.58% | 385,863 -45,035 | -10% | -$2.31M |
|
14
CVS Health
CVS
$92.8B
| $19.6M | 1.57% | 210,488 -32,800 | -13% | -$3.06M |
|
15
UnitedHealth
UNH
$281B
| $19M | 1.52% | 35,919 +236 | +0.7% | +$125K |
|
16
Lowe's Companies
LOW
$145B
| $18.8M | 1.5% | 94,325 +2,071 | +2% | +$413K |
|
|
17
InMode
INMD
$944M
| $18.4M | 1.47% | +516,557 | New | +$18.4M |
|
18
Halozyme
HALO
$8.56B
| $17.9M | 1.43% | 314,048 -82,569 | -21% | -$4.7M |
|
19
Labcorp
LH
$23.1B
| $17.8M | 1.43% | 75,716 +716 | +1% | +$169K |
|
20
American Express
AXP
$231B
| $17.7M | 1.41% | 119,726 -2,449 | -2% | -$362K |
|
21
Bristol-Myers Squibb
BMY
$96B
| $17.5M | 1.4% | 243,233 -45,161 | -16% | -$3.25M |
|
22
Abbott
ABT
$231B
| $17.5M | 1.4% | 159,163 +1,278 | +0.8% | +$140K |
|
23
Medifast
MED
$154M
| $17.3M | 1.39% | 150,400 +400 | +0.3% | +$46.1K |
|
24
Keysight
KEYS
$28.1B
| $17M | 1.36% | 99,232 -2,941 | -3% | -$503K |
|
25
Hologic
HOLX
$14.9B
| $16.5M | 1.32% | 220,714 -54,286 | -20% | -$4.06M |
|